NCT00073372View on ClinicalTrials.gov

A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

PHASE3TerminatedINTERVENTIONAL
Enrollment

808

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

December 31, 2005

Conditions
Cerebrovascular AccidentBrain IschemiaAcute Disease
Interventions
DRUG

Abciximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Centocor, Inc.

INDUSTRY

NCT00073372 - A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) | Biotech Hunter | Biotech Hunter